Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer

Sofia C Vaz; Judit A Adam; Roberto C Delgado Bolton; Pierre Vera; Wouter van Elmpt; Ken Herrmann; Rodney J Hicks; Yolande Lievens; Andrea Santos; Heiko Schöder; Bernard Dubray; Dimitris Visvikis; Esther G C Troost; Lioe-Fee de Geus-Oei

doi:10.1016/j.radonc.2021.12.048

Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[¹⁸F]FDG-PET/CT external beam radiation treatment planning in lung cancer

Radiother Oncol. 2022 Mar:168:37-39. doi: 10.1016/j.radonc.2021.12.048. Epub 2022 Jan 20.

Authors

Affiliations

¹ Nuclear Medicine-Radiopharmacology Champalimaud Foundation and Leiden University Medical Center, Lisbon, Portugal. Electronic address: sofia.vaz@fundacaochampalimaud.pt.
² Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands. Electronic address: j.a.adam@amsterdamumc.nl.
³ Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Logroño (La Rioja), Spain.
⁴ Henri Becquerel Cancer Center, QuantIF-LITIS EA 4108, Université de Rouen, Rouen, France. Electronic address: pierre.vera@chb.unicancer.fr.
⁵ Department of Radiation Oncology (MAASTRO), GROW - School for Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address: wouter.vanelmpt@maastro.nl.
⁶ Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany. Electronic address: ken.herrmann@uk-essen.de.
⁷ The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: rod.hicks@petermac.org.
⁸ Radiation Oncology Department, Ghent University Hospital and Ghent University, Ghent, Belgium. Electronic address: yolande.lievens@uzgent.be.
⁹ Nuclear Medicine Department, CUF Descobertas Hospital, Lisbon, Portugal.
¹⁰ Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: schoderh@mskcc.org.
¹¹ Department of Radiotherapy and Medical Physics, Centre Henri Becquerel, Rouen, France; QuantIF-LITIS EA4108, University of Rouen, France. Electronic address: bernard.dubray@chb.unicancer.fr.
¹² LaTIM, INSERM, UMR1101, Brest, France. Electronic address: visvikis@univ-brest.fr.
¹³ Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany, and Helmholtz Association/Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: esther.troost@uniklinikum-dresden.de.
¹⁴ Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: l.f.de_geus-oei@lumc.nl.

Abstract

In "Joint EANM/SNMMI/ESTRO Practice Recommendations for the Use of 2-[18F]FDG-PET/CT External Beam Radiation Treatment Planning in Lung Cancer V1.0" clinical indications for PET-CT in (non-)small cell lung cancer are highlighted and selective nodal irradiation is discussed. Additionally, concepts about target definition, target delineation and treatment evaluation are reviewed.

Keywords: FDG-PET/CT; Non-small cell lung cancer; Radiation treatment planning; Small cell lung cancer; Treatment response assessment.

Publication types

Review

MeSH terms

Fluorodeoxyglucose F18
Humans
Lung Neoplasms* / diagnostic imaging
Lung Neoplasms* / radiotherapy
Positron Emission Tomography Computed Tomography*
Positron-Emission Tomography
Radiopharmaceuticals

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States